Nutrición artificial, hiperglucemia, inmunosupresión

Revista Clinica Espanola

Volumn 197, Issue 12, 1997, Pages 836-840

  Cuerda Compes M C ^a   Camblor Alvarez M ^a   Breton Lesmes, I ^a   Garcia Peris P ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN;

BACTERIAL INFECTION; COMPARATIVE STUDY; DIABETES MELLITUS; HUMAN; HYPERGLYCEMIA; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; NEUTROPHIL; NUTRITIONAL SUPPORT; REVIEW; RISK FACTOR; TOTAL PARENTERAL NUTRITION;

BACTERIAL INFECTIONS; COMPLEMENT SYSTEM PROTEINS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; IMMUNOGLOBULINS; IMMUNOSUPPRESSION; LYMPHOCYTES; NEUTROPHILS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION, TOTAL; RISK FACTORS;

EID: 2442663036     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Chris Anderson D, Heimburger DC, Morgan SL, et al. Metabolic complications of total parenteral nutrition: effects of a nutrition support service. JPEN 1996, 20:206-210.
2. Valero MA, Alegre E, Gomis P, Moreno JM, Miguelez S, León-Sanz M. Clinical management of hyperglycaemic patients receiving total parenteral nutrition Clin Nutr 1996; 15:11-15.
3. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982; 72.439-450.
4. Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I, Hareli D Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabet Med 1996; 13.457-463
5. McMahon MM, Bristian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995, 9.1-9.
6. Gustafson KS, Vercellotti GM, Bendel CM, Hostetter MK. Molecular mimicry in Candida albicans Role of an integrin analogue in adhesion of the yeast to human endothelium. J Clin Invest 1991; 87 1 896-1.902
7. Mowat AG, Baum J Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971, 284:621-627.
8. Bagdade JD, Stewart M, Walters E Impaired granulocyte adherence A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978; 27:677-681
9. Nolan CM, Beaty HN, Bagdade JD Further characterization of the impaired bacteriodal function of granulocytes in patients with poorly controlled diabetes Diabetes 1978; 27:889-894
10. Bagdade JD, Nielson KL, Bulger RJ, Reversible abnormalities in phagocytic function in poorly controlled diabetic patients Am J Med Sci 1972; 263:451-456.
11. Esmann V Effect of insulin on human leukocytes Diabetes 1963, 12.545-549
12. Shah SV Wallin JD, Eilen SD Chemiluminescence and Superoxide anion production by leukocytes from diabetic patients J Clin Endocrinol Metab 1983, 57 402-409
13. Babior BM Oxygen-dependent microbial killing by phagocytes (first of two parts) N Engl J Med 1978; 298 659-668
14. Maridonneau-Parini I, Tnngale SM, Tajber AI, Identification of distinct activation pathways of the human neutrophil NADPH-oxidase. J Immunol 1986, 137:2.925-2.929.
15. Ortmeyer J, Mohsenin V. Glucose suppresses Superoxide generation in normal neutrophils: interference in phospholipase D activation Am J Physiol 1993; 264:C402-C410.
16. Nielson CP, Hindson DA. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 1989, 38 1.031-1 035
17. Gallacher SJ, Thomson G, Fraser WD, Fisher BM, Gemmell CG, McCuish AC Neutrophil bactericidal action in diabetes mellitus: evidence for association with blood glucose control Diabet Med 1995, 12:916-920.
18. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B Exploration des differentes etapes du fonctionnment des polynuclearies neutrophiles chez les patients diabetiques J Mal Vasc 1995; 20:107-112.
19. Ortmeyer J, Moshenin V. Inhibition of phospholipase D and superoxide generation by glucose in diabetic neutrophils Life Sci 1996; 59:255-262
20. Hosteller MK. The third component of complement: new functions for an old friend. J Lab Clin Med 1993, 122:491-496.
21. 3b proceeds by a transesterification reaction at the thiolester site. Nature 1982; 298:72-75.
22. 3 and Candida albicans. Diabetes 1990; 39.271-275
23. Danze PM, Tarjoram A, Rosseaux J, et al Evidence for an increased glycation of IgG in diabetic patients Clin Chim Acta 1987; 166:143-153.
24. Hammes HP, Kiefel V, Laube H, et al. Impaired agglutination of IgM resulting from non-enzymatic glycation in diabetes mellitus. Diab Res Clin Prac 1990; 9.37-42
25. Kennedy DM, Skillen AW, Self CH. Glycation of monoclonal antibodies impairs their ability to bind antigen. Clin Exp Immunol 1994; 98:245-251.
26. Dolhofer-Bliesener R, Gerbitz K. Impairment by glycation of immunoglobulin G Fc fragment function. Scand J Clin Lab Invest 1990; 50:739-746
27. Ardawi MS, Nasrat HA, Bahnassy AA Serum immunoglobulin concentrations in diabetic patients. Diabet Med 1994; 11:384-387.
28. MacCuish AC, Urbaniak SJ, Campbell CJ. Phytohemagglutinin transformation and circulating lymphocyte subpopulation in insulin-dependent diabetic patients. Diabetes 1974; 23:708.
29. Mencacci A, Romani L, Mosci P, et al Susceptibility to Candida albicans infection correlates with the induction of a biased Th2-like antifungal response. Cell Immunol 1993; 150:36-44.
30. Li YM, Tan AX, Vlassara H Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nat Med 1995; 1:1 057-1.061.
31. LeRoith D, Shiloach J, Roth J, Lesniak MA. Insulin or a closely related molecule is native to Escherichia coli. J Biochem 1981; 256.6.533-6.536.
32. Watanabe M, Po L. Membrane-bound 3beta and 17beta-hydroxysteroid dehydrogenase and its role in steroid transport in membrane vesicles of Pseudomonas testosteroni. J Steroid Biochem 1976; 7:171-175
33. Loose DS, Schurman DJ, Feldman D. A corticosteroid binding protein and endogenous ligand in C. albicans indicating a possible steroid-receptor system. Nature 1981; 293:477-479.
34. Hostetter MK, Lorenz JS, Preus L, Kendrick KE. The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. J Infect Dis 1990, 161.761-768.
35. Souba WW Nutritional support. N Engl J Med 1997, 336:41-48.
36. Pomposelli JJ, Bristian BR. Is total parenteral nutrition immunosuppressive? New Horiz 1994; 2:224-229.
37. Curry CR, Quie PG. Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med 1971; 285:1.221-1.225.
38. Ryan JA, Abel RM, Abbot WM, et al. Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients N Engl J Med 1974; 290 757-761
39. Overett TK, Bnstian BR, Lowry SF, et al. Total parenteral nutrition in patients with insulin-requiring diabetes mellitus J Am Coll Nutr 1986; 5:79-89.
40. Porter K, Bnstian BR, Blackburn G. Guidewire catheter exchange with triple culture technique in the management of catheter sepsis. JPEN 1986; 12 79-89
41. Baxter JK, Babineau TJ, Apovian CM, et al. Perioperative glucose control predicts increased nosocomial infection in diabetes. Crit Care Med 1990; 18:S207
42. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. Perioperative Total Parenteral Nutrition in Surgical Patients. N Engl J Med 1991, 325.525-532.
43. Moore FA, Feliciano DV, Andrassy RJ, et al. Early Enterai Feeding, compared with Parenteral Nutrition, reduces postoperative septic complications. The results of a Meta-analysis. Ann Surg 1992, 216:172-183
44. McMahon MM, Rizza RA Nutrition support in hospitalized patients with diabetes mellitus Mayo Clin Proc 1996; 71:587-594